Skip to content

Clinical and Molecular Study of CHARGE Syndrom

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03186144
Acronym
CHARGE
Enrollment
141
Registered
2017-06-14
Start date
2012-02-29
Completion date
2015-12-31
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development Abnormalies, Inclusion on Clinical Criteria of the Syndrome

Brief summary

1. Clinical description of a French cohort of patients with CHARGE syndrome. 2. Search any phenotype-genotype correlation in typical, atypical or incomplete form of the syndrome 3. Using Next generation Sequencing, try to identify other genes involved in this syndrome, as the CHD7 gene is involved in only 40-60% of cases

Interventions

GENETICBlodd punction for genetic analysis

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Clinical criteria Major criteria: * Ocular coloboma * Chonamal atresia and/or cleft palate * Semi-CircularCanals hypoplasia Minor criteria: * Cranial nerves * Hypothalamic-pituitary deficiency * Internal or external ear malformation * Cardiac, esophageal malformations * Intellectual Deficiency Diagnosis criteria: * Typical CHARGE: 3 major criteria or 2 major + 2 minor * Partial CHARGE: 2 major + 1 minor * Atypical CHARGE: 2 major without minor or 1 major + 2 minor

Exclusion criteria

* Absent consentment for genetic analysis

Design outcomes

Primary

MeasureTime frame
Description Clinical and molecular analysis of a French cohort CHARGE12 month
Execution of the socio-adaptive scale, parental scale12 month
Rate of mutations of CHD7 and / or type of mutations12 month
analysis CHD7 gene from the patient's DNA12 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026